Annual EBIT
-$160.07 M
-$37.54 M-30.64%
December 31, 2023
Summary
- As of February 7, 2025, PLRX annual earnings before interest & taxes is -$160.07 million, with the most recent change of -$37.54 million (-30.64%) on December 31, 2023.
- During the last 3 years, PLRX annual EBIT has fallen by -$118.42 million (-284.37%).
- PLRX annual EBIT is now -12903.17% below its all-time high of -$1.23 million, reached on December 31, 2019.
Performance
PLRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$56.89 M
-$1.90 M-3.46%
September 30, 2024
Summary
- As of February 7, 2025, PLRX quarterly earnings before interest & taxes is -$56.89 million, with the most recent change of -$1.90 million (-3.46%) on September 30, 2024.
- Over the past year, PLRX quarterly EBIT has dropped by -$1.90 million (-3.46%).
- PLRX quarterly EBIT is now -234.73% below its all-time high of $42.22 million, reached on December 31, 2019.
Performance
PLRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$199.17 M
-$15.72 M-8.57%
September 30, 2024
Summary
- As of February 7, 2025, PLRX TTM earnings before interest & taxes is -$199.17 million, with the most recent change of -$15.72 million (-8.57%) on September 30, 2024.
- Over the past year, PLRX TTM EBIT has dropped by -$15.72 million (-8.57%).
- PLRX TTM EBIT is now -925.51% below its all-time high of $24.13 million, reached on March 31, 2020.
Performance
PLRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PLRX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.6% | -3.5% | -8.6% |
| 3 y3 years | -284.4% | -3.5% | -8.6% |
| 5 y5 years | -417.8% | -234.7% | -10000.0% |
PLRX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -64.6% | at low | -133.8% | at low | -104.8% | at low |
| 5 y | 5-year | <-9999.0% | at low | -234.7% | at low | -925.5% | at low |
| alltime | all time | <-9999.0% | at low | -234.7% | at low | -925.5% | at low |
Pliant Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$56.89 M(+3.5%) | -$199.17 M(+8.6%) |
| Jun 2024 | - | -$54.99 M(+18.2%) | -$183.45 M(+8.3%) |
| Mar 2024 | - | -$46.51 M(+14.0%) | -$169.34 M(+5.8%) |
| Dec 2023 | -$160.07 M(+30.6%) | -$40.79 M(-0.9%) | -$160.07 M(+3.9%) |
| Sep 2023 | - | -$41.17 M(+0.7%) | -$154.02 M(+7.6%) |
| Jun 2023 | - | -$40.87 M(+9.8%) | -$143.17 M(+8.7%) |
| Mar 2023 | - | -$37.24 M(+7.2%) | -$131.67 M(+7.5%) |
| Dec 2022 | -$122.53 M(+26.0%) | -$34.74 M(+14.6%) | -$122.53 M(+9.3%) |
| Sep 2022 | - | -$30.31 M(+3.2%) | -$112.11 M(+2.9%) |
| Jun 2022 | - | -$29.37 M(+4.5%) | -$108.91 M(+6.3%) |
| Mar 2022 | - | -$28.10 M(+15.5%) | -$102.44 M(+5.3%) |
| Dec 2021 | -$97.26 M | -$24.33 M(-10.3%) | -$97.26 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$27.11 M(+18.4%) | -$91.95 M(+12.8%) |
| Jun 2021 | - | -$22.90 M(-0.1%) | -$81.50 M(+7.8%) |
| Mar 2021 | - | -$22.92 M(+20.5%) | -$75.57 M(+81.5%) |
| Dec 2020 | -$41.65 M(+3283.0%) | -$19.02 M(+14.1%) | -$41.65 M(-312.6%) |
| Sep 2020 | - | -$16.66 M(-1.9%) | $19.59 M(-14.4%) |
| Jun 2020 | - | -$16.98 M(-254.2%) | $22.89 M(-5.1%) |
| Mar 2020 | - | $11.01 M(-73.9%) | $24.13 M(-2060.0%) |
| Dec 2019 | -$1.23 M(-96.0%) | $42.22 M(-416.0%) | -$1.23 M(-97.2%) |
| Sep 2019 | - | -$13.36 M(-15.1%) | -$43.45 M(+44.4%) |
| Jun 2019 | - | -$15.74 M(+9.7%) | -$30.09 M(+109.7%) |
| Mar 2019 | - | -$14.35 M | -$14.35 M |
| Dec 2018 | -$30.91 M | - | - |
FAQ
- What is Pliant Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pliant Therapeutics?
- What is Pliant Therapeutics annual EBIT year-on-year change?
- What is Pliant Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly EBIT year-on-year change?
- What is Pliant Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pliant Therapeutics?
- What is Pliant Therapeutics TTM EBIT year-on-year change?
What is Pliant Therapeutics annual earnings before interest & taxes?
The current annual EBIT of PLRX is -$160.07 M
What is the all time high annual EBIT for Pliant Therapeutics?
Pliant Therapeutics all-time high annual earnings before interest & taxes is -$1.23 M
What is Pliant Therapeutics annual EBIT year-on-year change?
Over the past year, PLRX annual earnings before interest & taxes has changed by -$37.54 M (-30.64%)
What is Pliant Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of PLRX is -$56.89 M
What is the all time high quarterly EBIT for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly earnings before interest & taxes is $42.22 M
What is Pliant Therapeutics quarterly EBIT year-on-year change?
Over the past year, PLRX quarterly earnings before interest & taxes has changed by -$1.90 M (-3.46%)
What is Pliant Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of PLRX is -$199.17 M
What is the all time high TTM EBIT for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM earnings before interest & taxes is $24.13 M
What is Pliant Therapeutics TTM EBIT year-on-year change?
Over the past year, PLRX TTM earnings before interest & taxes has changed by -$15.72 M (-8.57%)